Microbix Biosystems Inc. MBXBF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 16.86% | -33.64% | -29.91% | -41.09% | -32.13% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 16.86% | -33.64% | -29.91% | -41.09% | -32.13% |
| Cost of Revenue | -9.12% | -15.13% | 8.91% | -22.45% | -11.98% |
| Gross Profit | 54.63% | -46.24% | -53.62% | -56.45% | -49.08% |
| SG&A Expenses | 5.34% | 1.42% | 2.80% | 6.54% | 3.49% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -1.80% | -3.44% | 4.48% | -8.28% | -3.70% |
| Operating Income | 50.52% | -544.33% | -188.50% | -290.29% | -1,128.91% |
| Income Before Tax | 50.91% | -7,340.97% | -236.75% | -357.50% | -758.51% |
| Income Tax Expenses | -- | -- | -- | -136.68% | -- |
| Earnings from Continuing Operations | 50.91% | -7,340.97% | -236.75% | -433.02% | -758.51% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 50.91% | -7,340.97% | -236.75% | -433.02% | -758.51% |
| EBIT | 50.52% | -544.33% | -188.50% | -290.29% | -1,128.91% |
| EBITDA | 78.94% | -215.22% | -139.37% | -225.63% | -257.82% |
| EPS Basic | 50.00% | -7,600.00% | -233.33% | -443.48% | -746.15% |
| Normalized Basic EPS | 50.94% | -4,800.00% | -235.71% | -304.00% | -1,866.67% |
| EPS Diluted | 50.57% | -7,600.00% | -239.53% | -452.17% | -769.23% |
| Normalized Diluted EPS | 50.94% | -4,800.00% | -235.71% | -304.00% | -1,866.67% |
| Average Basic Shares Outstanding | -2.15% | -0.84% | 3.07% | -2.92% | 2.73% |
| Average Diluted Shares Outstanding | -2.16% | -1.35% | 2.59% | -3.43% | 2.17% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |